Rapt Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Rapt Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapt Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapt Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $652k | 26k | 24.85 |
| 2023-09-30 | $439k | 26k | 16.62 |
| 2023-06-30 | $457k | 24k | 18.70 |
| 2023-03-31 | $35k | 1.7k | 19.80 |
| 2022-12-31 | $319k | 17k | 19.33 |
| 2022-06-30 | $292k | 16k | 18.87 |
| 2022-03-31 | $299k | 14k | 22.02 |
| 2021-12-31 | $397k | 11k | 36.14 |
| 2021-03-31 | $93k | 4.2k | 22.12 |
| 2020-12-31 | $251k | 13k | 19.76 |
| 2020-09-30 | $227k | 8.2k | 27.51 |
| 2020-06-30 | $830k | 29k | 29.03 |
| 2020-03-31 | $11k | 499 | 22.13 |
| 2019-12-31 | $14k | 507 | 27.61 |